Encompass Health Corp (EHC) Financials
$121.71
$0.67
(0.55%)
As on 11-Sep-2026 16:10EDT
Market cap
$12,007 Mln
Revenue (TTM)
$6,206 Mln
P/E Ratio
20.3
P/B Ratio
4.6
Div. Yield
0.6 %
Income Statement ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
6,206.10
|
5,935.20
|
5,373.20
|
4,801.20
|
4,348.60
|
4,014.90
|
|
|
|
|
|
|
Cost of Revenue
|
1,733.50
|
254.40
|
3,140.00
|
2,818.40
|
2,595.40
|
2,311.50
|
|
|
|
|
|
|
Gross Profit
|
4,538.70
|
5,680.80
|
2,233.20
|
1,982.80
|
1,753.20
|
1,703.40
|
|
|
|
|
|
|
Operating Expenses
|
3,421.70
|
4,627.70
|
1,368.70
|
258.00
|
1,123.00
|
1,044.00
|
|
|
|
|
|
|
Operating Profit (EBIT)
|
1,117.00
|
1,053.10
|
864.50
|
1,724.80
|
630.20
|
659.40
|
|
|
|
|
|
|
Other Income
|
--
|
--
|
--
|
--
|
--
|
15.30
|
|
|
|
|
|
|
Profit before Tax
|
1,027.90
|
953.00
|
749.60
|
607.20
|
450.80
|
505.00
|
|
|
|
|
|
|
Provision for Tax
|
210.30
|
192.90
|
150.20
|
132.20
|
100.10
|
101.90
|
|
|
|
|
|
|
Profit after Tax (Net Income)
|
621.00
|
566.20
|
455.70
|
352.00
|
271.00
|
412.20
|
|
|
|
|
|
|
Minority Interest
|
-212.30
|
-192.90
|
-140.90
|
-107.60
|
-94.90
|
-105.00
|
|
|
|
|
|
|
Consolidated Profit
|
271.90
|
564.70
|
452.90
|
349.60
|
269.80
|
412.20
|
|
|
|
|
|
Liabilities ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
2,597.70
|
2,438.20
|
2,067.00
|
1,647.50
|
1,310.30
|
1,911.30
|
|
|
|
|
|
|
Minority Interest
|
-212.30
|
--
|
--
|
--
|
--
|
445.70
|
|
|
|
|
|
|
Non-Current Liabilities
|
3,123.00
|
2,977.50
|
2,844.50
|
3,148.80
|
3,198.70
|
3,716.90
|
|
|
|
|
|
|
Current Liabilities
|
873.40
|
836.40
|
841.00
|
656.40
|
575.90
|
748.80
|
|
|
|
|
|
|
Total Liabilities
|
8,330.90
|
7,089.70
|
6,534.70
|
6,102.40
|
5,636.50
|
6,864.90
|
|
|
|
|
|
Assets ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
6,416.50
|
6,183.80
|
5,647.80
|
5,260.60
|
4,919.30
|
5,943.50
|
|
|
|
|
|
|
Current Assets
|
1,041.00
|
905.90
|
886.90
|
841.80
|
717.20
|
921.40
|
|
|
|
|
|
|
Total Assets
|
8,330.90
|
7,089.70
|
6,534.70
|
6,102.40
|
5,636.50
|
6,864.90
|
|
|
|
|
|
|
Total Debt*
|
2,842.30
|
2,713.90
|
2,713.80
|
2,932.80
|
2,992.30
|
3,481.40
|
|
|
|
|
|
|
Net Current Assets
|
167.60
|
69.50
|
45.90
|
185.40
|
141.30
|
172.60
|
|
|
|
|
|
Cashflow ($ Mln) |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
1,175.60
|
1,002.80
|
850.80
|
705.80
|
715.80
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-762.80
|
-653.30
|
-602.80
|
-627.00
|
-666.30
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-433.00
|
-330.60
|
-197.20
|
-145.70
|
-240.10
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
--
|
--
|
--
|
--
|
-190.60
|
|
|
|
|
|
Financials Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS ($)
|
6.14
|
5.55
|
4.45
|
3.47
|
2.69
|
4.11
|
|
|
|
|
|
|
Cash EPS ($)
|
5.99
|
8.77
|
7.38
|
6.10
|
5.11
|
6.67
|
|
|
|
|
|
|
Adjusted Book Value ($)
|
26.29
|
23.90
|
20.21
|
16.23
|
13.00
|
19.07
|
|
|
|
|
|
|
Dividend per Share ($)
|
0.63
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Cash Flow per Share ($)
|
--
|
11.53
|
9.80
|
8.38
|
7.00
|
7.14
|
|
|
|
|
|
|
Free Cash Flow per Share ($)
|
--
|
4.31
|
3.52
|
2.64
|
1.21
|
1.64
|
|
|
|
|
|
Profitability Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
11.40
|
9.74
|
7.93
|
5.59
|
7.83
|
|
|
|
|
|
|
ROE (%)
|
16.23
|
25.14
|
24.54
|
23.80
|
16.82
|
23.56
|
|
|
|
|
|
|
ROA (%)
|
7.77
|
8.31
|
7.21
|
6.00
|
4.34
|
6.19
|
|
|
|
|
|
|
EBIT Margin (%)
|
18.59
|
18.13
|
16.51
|
15.24
|
14.41
|
16.67
|
|
|
|
|
|
|
Net Margin (%)
|
10.01
|
9.54
|
8.48
|
7.33
|
6.23
|
10.23
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Growth Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
9.47
|
0.10
|
0.12
|
0.10
|
0.08
|
0.13
|
|
|
|
|
|
|
EBIT Growth (%)
|
16.43
|
21.33
|
21.21
|
16.81
|
-6.39
|
24.73
|
|
|
|
|
|
|
Net Profit Growth (%)
|
15.88
|
24.25
|
29.46
|
29.89
|
-34.26
|
45.04
|
|
|
|
|
|
|
EPS Growth (%)
|
20.05
|
0.25
|
0.28
|
0.29
|
-0.35
|
0.45
|
|
|
|
|
|
|
Book Value Growth (%)
|
16.44
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Valuation Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
20.32
|
19.12
|
20.73
|
19.24
|
22.25
|
15.85
|
|
|
|
|
|
|
Price / Book Value
|
4.60
|
4.44
|
4.57
|
4.11
|
4.60
|
3.42
|
|
|
|
|
|
|
Dividend Yield (%)
|
0.63
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
EV/EBITDA
|
9.78
|
9.54
|
10.14
|
9.51
|
10.34
|
11.21
|
|
|
|
|
|
|
Close Price ($)
|
101.08
|
106.14
|
92.35
|
66.72
|
59.81
|
51.89
|
|
|
|
|
|
|
High Price ($)
|
127.99
|
127.99
|
104.55
|
72.06
|
59.91
|
71.30
|
|
|
|
|
|
|
Low Price ($)
|
92.77
|
87.85
|
65.99
|
51.15
|
42.16
|
44.77
|
|
|
|
|
|
|
Market Cap ($ Cr)
|
12,007.10
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
Solvency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
1.00
|
1.11
|
1.31
|
1.78
|
2.28
|
1.82
|
|
|
|
|
|
|
Short term debt to equity ratio
|
0.02
|
0.03
|
0.08
|
0.03
|
0.04
|
0.03
|
|
|
|
|
|
|
Current Ratio
|
1.19
|
1.08
|
1.05
|
1.28
|
1.25
|
1.23
|
|
|
|
|
|
|
Quick Ratio
|
1.19
|
--
|
--
|
1.17
|
1.19
|
1.14
|
|
|
|
|
|
|
Interest Coverage
|
9.18
|
8.74
|
6.46
|
5.10
|
3.57
|
4.07
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 | Dec-16 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
11.07
|
10.43
|
11.14
|
12.74
|
12.34
|
12.51
|
|
|
|
|
|
|
Asset Turnover
|
0.78
|
0.87
|
0.85
|
0.82
|
0.70
|
0.60
|
|
|
|
|
|
|
Receivable days
|
--
|
37.48
|
41.14
|
43.68
|
43.63
|
48.45
|
|
|
|
|
|
|
Inventory Days
|
--
|
--
|
8.46
|
6.76
|
6.80
|
10.31
|
|
|
|
|
|
|
Payable days
|
--
|
250.68
|
19.83
|
19.63
|
18.78
|
19.67
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
--
|
29.76
|
30.81
|
31.65
|
39.09
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
